Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Brian Bergmark, M.D.

Co-Author

This page shows the publications co-authored by Brian Bergmark and Kazuma Oyama.
Connection Strength

1.880
  1. Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial. Eur Heart J. 2021 12 14; 42(47):4821-4829.
    View in: PubMed
    Score: 0.975
  2. Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization. J Am Coll Cardiol. 2021 01 26; 77(3):259-267.
    View in: PubMed
    Score: 0.905
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.